Glimibrit MV 1mg/500mg/0.2mg Tablet
Marketer
Elbrit Life Sciences
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Glimibrit MV 1mg/500mg/0.2mg Tablet
Diabetic patients (adults) utilize the anti-diabetic combination medication, Glimibrit MV 1mg/500mg/0.2mg Tablet, to manage type 2 diabetes mellitus. This medication regulates blood glucose. Administer this tablet with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical guidance risks elevated blood glucose, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management program, including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common adverse effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential to mitigate this risk. Alcohol consumption should be avoided due to its hypoglycemic potential. Other possible side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring, along with blood cell and liver function tests as directed by your physician, are necessary.
Uses of Glimibrit MV 1mg/500mg/0.2mg Tablet
Managing type 2 diabetes
Major Benefits of Glimibrit MV 1mg/500mg/0.2mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimibrit MV 1mg/500mg/0.2mg tablets on an empty stomach.
Common Side effects of Glimibrit MV 1mg/500mg/0.2mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimibrit MV 1mg/500mg/0.2mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume Glimibrit MV 1mg/500mg/0.2mg tablets on an empty stomach.
How Glimibrit MV 1mg/500mg/0.2mg Tablet works:
Each Glimibrit MV tablet (1mg/500mg/0.2mg) combines three distinct antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimibrit MV 1mg/500mg/0.2mg tablets with alcohol is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Using Glimibrit MV 1mg/500mg/0.2mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against potential dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Glimibrit MV 1mg/500mg/0.2mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Glimibrit MV 1mg/500mg/0.2mg tablets is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Furthermore, this medication is unsuitable for patients experiencing severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Glimibrit MV 1mg/500mg/0.2mg tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate hepatic dysfunction, a low initial dose is usually prescribed; however, the medication is unsuitable for individuals with severe liver disease.
What if you forget to take Glimibrit MV 1mg/500mg/0.2mg Tablet :
Should you forget to take a Glimibrit MV 1mg/500mg/0.2mg Tablet, administer it immediately upon remembrance. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed amount at one time.
Facts to Know About Glimibrit MV 1mg/500mg/0.2mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently